{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:52:08Z","timestamp":1781823128104,"version":"3.54.5"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12033-026-01563-4","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:21:06Z","timestamp":1773688866000},"page":"3068-3090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR-Cas9: Genome Engineering and Future Vaccine Applications"],"prefix":"10.1007","volume":"68","author":[{"given":"Masoumeh","family":"Madhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1451-3996","authenticated-orcid":false,"given":"Pourya","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"issue":"2","key":"1563_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","volume":"21","author":"AJ Pollard","year":"2021","unstructured":"Pollard, A. J., & Bijker, E. M. (2021). A guide to vaccinology: From basic principles to new developments. Nature Reviews Immunology., 21(2), 83\u2013100.","journal-title":"Nature Reviews Immunology."},{"issue":"1","key":"1563_CR2","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","volume":"25","author":"CA Lino","year":"2018","unstructured":"Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018). Delivering CRISPR: A review of the challenges and approaches. Drug Delivery, 25(1), 1234\u20131257.","journal-title":"Drug Delivery"},{"issue":"7","key":"1563_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013). ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends in biotechnology., 31(7), 397\u2013405.","journal-title":"Trends in biotechnology."},{"key":"1563_CR4","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S247271","author":"P Gholizadeh","year":"2020","unstructured":"Gholizadeh, P., K\u00f6se, \u015e, Dao, S., Ganbarov, K., Tanomand, A., Dal, T., et al. (2020). How CRISPR-Cas system could be used to combat antimicrobial resistance. Infection and Drug Resistance. https:\/\/doi.org\/10.2147\/IDR.S247271","journal-title":"Infection and Drug Resistance"},{"issue":"14","key":"1563_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34692","volume":"10","author":"H Kadkhoda","year":"2024","unstructured":"Kadkhoda, H., Gholizadeh, P., Samadi Kafil, H., Ghotaslou, R., Pirzadeh, T., Ahangarzadeh Rezaee, M., et al. (2024). Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance. Heliyon., 10(14), Article e34692.","journal-title":"Heliyon."},{"issue":"1","key":"1563_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12941-021-00455-6","volume":"20","author":"P Gholizadeh","year":"2021","unstructured":"Gholizadeh, P., Aghazadeh, M., Ghotaslou, R., Rezaee, M. A., Pirzadeh, T., Cui, L., et al. (2021). Role of CRISPR-Cas system on antibiotic resistance patterns of enterococcus faecalis. Annals of Clinical Microbiology and Antimicrobials, 20(1), 49.","journal-title":"Annals of Clinical Microbiology and Antimicrobials"},{"issue":"2","key":"1563_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.34172\/bshj.20","volume":"1","author":"P Gholizadeh","year":"2024","unstructured":"Gholizadeh, P., Faghfuri, E., Ganbarov, K., & Kafil, H. S. (2024). Exploiting CRISPR\/Cas system in controlling antibiotic resistance of bacteria. BioSocial Health journal., 1(2), 61\u201363.","journal-title":"BioSocial Health journal."},{"key":"1563_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.107151","volume":"199","author":"H Kadkhoda","year":"2025","unstructured":"Kadkhoda, H., Gholizadeh, P., Ghotaslou, R., Nabizadeh, E., Pirzadeh, T., Ahangarzadeh Rezaee, M., et al. (2025). Role of CRISPR-cas system on virulence traits and carbapenem resistance in clinical Klebsiella pneumoniae isolates. Microbial Pathogenesis, 199, Article 107151.","journal-title":"Microbial Pathogenesis"},{"issue":"1","key":"1563_CR9","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12879-024-09451-5","volume":"24","author":"H Kadkhoda","year":"2024","unstructured":"Kadkhoda, H., Gholizadeh, P., Ghotaslou, R., Pirzadeh, T., Ahangarzadeh Rezaee, M., Nabizadeh, E., et al. (2024). Prevalence of the CRISPR-cas system and its association with antibiotic resistance in clinical Klebsiella pneumoniae isolates. BMC Infectious Diseases, 24(1), 554.","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"1563_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13369-022-07266-7","volume":"48","author":"M Naeem","year":"2023","unstructured":"Naeem, M., Alkhodairy, H. F., Ashraf, I., & Khalil, A. B. (2023). CRISPR\/Cas System toward the development of next-generation recombinant vaccines: Current scenario and future prospects. Arabian Journal for Science and Engineering, 48(1), 1\u201311.","journal-title":"Arabian Journal for Science and Engineering"},{"issue":"1","key":"1563_CR11","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10142-025-01777-w","volume":"25","author":"D Majumdar","year":"2025","unstructured":"Majumdar, D., Hann, E., Short, K. R., Schat, K. A., & Challagulla, A. (2025). Genetic strategies for avian influenza resilience in poultry: From host-pathogen interaction studies to precision breeding. Functional & Integrative Genomics., 25(1), 252.","journal-title":"Functional & Integrative Genomics."},{"issue":"3","key":"1563_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12030226","volume":"12","author":"J-F Zhang","year":"2024","unstructured":"Zhang, J.-F., Park, J.-Y., Kim, S.-W., Choi, Y.-R., Cha, S.-Y., Jang, H.-K., et al. (2024). Development of a highly efficient CRISPR\/Cas9-mediated herpesvirus of Turkey-based vaccine against novel variant infectious bursal disease virus. Vaccines (Basel), 12(3), Article 226.","journal-title":"Vaccines (Basel)"},{"issue":"20","key":"1563_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202001300","volume":"7","author":"P Ma","year":"2020","unstructured":"Ma, P., Meng, Q., Sun, B., Zhao, B., Dang, L., Zhong, M., et al. (2020). MeCas12a, a highly sensitive and specific system for COVID\u201019 detection. Advanced Science, 7(20), Article 2001300.","journal-title":"Advanced Science"},{"issue":"15","key":"1563_CR14","first-page":"6972","volume":"27","author":"M Naveed","year":"2023","unstructured":"Naveed, M., Ali, I., Aziz, T., Ain, N., Shabbir, M. A., Javed, K., et al. (2023). Halogens engineering-based design of agonists for boosting expression of frataxin protein in Friedreich\u2019s ataxia. European Review for Medical and Pharmacological Sciences, 27(15), 6972\u20136984.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"11","key":"1563_CR15","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1080\/14760584.2022.2112952","volume":"21","author":"S Bhujbal","year":"2022","unstructured":"Bhujbal, S., Bhujbal, R., & Giram, P. (2022). An overview: CRISPR\/Cas-based gene editing for viral vaccine development. Expert Review of Vaccines, 21(11), 1581\u20131593.","journal-title":"Expert Review of Vaccines"},{"issue":"6","key":"1563_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.tim.2025.02.006","volume":"33","author":"F Yang","year":"2025","unstructured":"Yang, F., Aliyari, S., Zhu, Z., Zheng, H., Cheng, G., & Zhang, S. (2025). CRISPR-Cas: A game-changer in vaccine development and the fight against viral infections. Trends in Microbiology, 33(6), 650\u2013664.","journal-title":"Trends in Microbiology"},{"issue":"11","key":"1563_CR17","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1007\/s10096-017-3036-2","volume":"36","author":"P Gholizadeh","year":"2017","unstructured":"Gholizadeh, P., Aghazadeh, M., Asgharzadeh, M., & Kafil, H. S. (2017). Suppressing the CRISPR\/Cas adaptive immune system in bacterial infections. European Journal of Clinical Microbiology & Infectious Diseases, 36(11), 2043\u20132051.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"5","key":"1563_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","volume":"156","author":"H Nishimasu","year":"2014","unstructured":"Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., et al. (2014). Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 156(5), 935\u2013949.","journal-title":"Cell"},{"issue":"6","key":"1563_CR19","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.cell.2017.07.037","volume":"170","author":"LB Harrington","year":"2017","unstructured":"Harrington, L. B., Doxzen, K. W., Ma, E., Liu, J.-J., Knott, G. J., Edraki, A., et al. (2017). A broad-spectrum inhibitor of CRISPR-Cas9. Cell, 170(6), 1224\u20131233.","journal-title":"Cell"},{"key":"1563_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/bs.pmbts.2020.12.001","volume":"178","author":"R Gupta","year":"2021","unstructured":"Gupta, R., Gupta, D., Ahmed, K. T., Dey, D., Singh, R., Swarnakar, S., et al. (2021). Modification of Cas9, gRNA and PAM: Key to further regulate genome editing and its applications. Progress in Molecular Biology and Translational Science., 178, 85\u201398.","journal-title":"Progress in Molecular Biology and Translational Science."},{"issue":"6","key":"1563_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201902312","volume":"7","author":"H Manghwar","year":"2020","unstructured":"Manghwar, H., Li, B., Ding, X., Hussain, A., Lindsey, K., Zhang, X., et al. (2020). CRISPR\/Cas systems in genome editing: Methodologies and tools for sgRNA design, off\u2010target evaluation, and strategies to mitigate off\u2010target effects. Advanced Science, 7(6), Article 1902312.","journal-title":"Advanced Science"},{"issue":"1","key":"1563_CR22","volume":"3","author":"H Yu","year":"2023","unstructured":"Yu, H., Jing, W., & Cheng, X. (2023). CRISPR-Cas-and aptamer-based systems for diagnosing pathogens: A review. Zoonoses (Basel, Switzerland), 3(1), Article 978.","journal-title":"Zoonoses (Basel, Switzerland)"},{"issue":"4","key":"1563_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.synbio.2020.08.003","volume":"5","author":"Z Jiang","year":"2020","unstructured":"Jiang, Z., Hong, X., Zhang, S., Yao, R., & Xiao, Y. (2020). CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants. Synthetic and Systems Biotechnology., 5(4), 277\u2013292.","journal-title":"Synthetic and Systems Biotechnology."},{"issue":"49","key":"1563_CR24","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1021\/acs.biochem.1c00354","volume":"60","author":"K Babu","year":"2021","unstructured":"Babu, K., Kathiresan, V., Kumari, P., Newsom, S., Parameshwaran, H. P., Chen, X., et al. (2021). Coordinated actions of Cas9 HNH and RuvC nuclease domains are regulated by the bridge helix and the target DNA sequence. Biochemistry, 60(49), 3783\u20133800.","journal-title":"Biochemistry"},{"key":"1563_CR25","doi-asserted-by":"publisher","first-page":"1072733","DOI":"10.3389\/fmolb.2022.1072733","volume":"9","author":"J Wang","year":"2023","unstructured":"Wang, J., Arantes, P. R., Ahsan, M., Sinha, S., Kyro, G. W., Maschietto, F., et al. (2023). Twisting and swiveling domain motions in Cas9 to recognize target DNA duplexes, make double-strand breaks, and release cleaved duplexes. Frontiers in Molecular Biosciences., 9, 1072733.","journal-title":"Frontiers in Molecular Biosciences."},{"issue":"7","key":"1563_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41434-022-00319-4","volume":"29","author":"J Lv","year":"2022","unstructured":"Lv, J., Xi, H., Lv, X., Zhou, Y., Wang, J., Chen, H., et al. (2022). Two high-fidelity variants: EfSaCas9 and SaCas9-HF, which one is better? Gene Therapy., 29(7), 458\u2013463.","journal-title":"Gene Therapy."},{"issue":"18","key":"1563_CR27","doi-asserted-by":"publisher","first-page":"9880","DOI":"10.1093\/nar\/gkad702","volume":"51","author":"L Zhang","year":"2023","unstructured":"Zhang, L., He, W., Fu, R., Wang, S., Chen, Y., & Xu, H. (2023). Guide-specific loss of efficiency and off-target reduction with Cas9 variants. Nucleic acids research., 51(18), 9880\u20139893.","journal-title":"Nucleic acids research."},{"issue":"1","key":"1563_CR28","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1038\/s41467-023-41829-y","volume":"14","author":"L Zhao","year":"2023","unstructured":"Zhao, L., Koseki, S. R. T., Silverstein, R. A., Amrani, N., Peng, C., Kramme, C., et al. (2023). PAM-flexible genome editing with an engineered chimeric Cas9. Nature Communications, 14(1), 6175.","journal-title":"Nature Communications"},{"issue":"2","key":"1563_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/pbi.12465","volume":"14","author":"J Lee","year":"2016","unstructured":"Lee, J., Chung, J. H., Kim, H. M., Kim, D. W., & Kim, H. (2016). Designed nucleases for targeted genome editing. Plant biotechnology journal., 14(2), 448\u2013462.","journal-title":"Plant biotechnology journal."},{"issue":"6121","key":"1563_CR30","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., et al. (2013). Multiplex genome engineering using CRISPR\/Cas systems. Science, 339(6121), 819\u2013823.","journal-title":"Science"},{"issue":"3","key":"1563_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.cell.2021.01.019","volume":"184","author":"LS Qi","year":"2021","unstructured":"Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., et al. (2021). Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 184(3), 844.","journal-title":"Cell"},{"issue":"2","key":"1563_CR32","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","volume":"154","author":"LA Gilbert","year":"2013","unstructured":"Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., et al. (2013). CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell, 154(2), 442\u2013451.","journal-title":"Cell"},{"key":"1563_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01442-z","author":"BL Ruis","year":"2025","unstructured":"Ruis, B. L., Bielinsky, A. K., & Hendrickson, E. A. (2025). Gene editing and CRISPR-dependent homology-mediated end joining. Experimental & Molecular Medicine. https:\/\/doi.org\/10.1038\/s12276-025-01442-z","journal-title":"Experimental & Molecular Medicine"},{"issue":"18","key":"1563_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186461","volume":"21","author":"H Yang","year":"2020","unstructured":"Yang, H., Ren, S., Yu, S., Pan, H., Li, T., Ge, S., et al. (2020). Methods favoring homology-directed repair choice in response to CRISPR\/Cas9 induced-double strand breaks. International Journal of Molecular Sciences, 21(18), Article 6461.","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"1563_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.tibtech.2019.03.008","volume":"37","author":"KA Molla","year":"2019","unstructured":"Molla, K. A., & Yang, Y. (2019). CRISPR\/Cas-mediated base editing: Technical considerations and practical applications. Trends in Biotechnology, 37(10), 1121\u20131142.","journal-title":"Trends in Biotechnology"},{"issue":"1","key":"1563_CR36","doi-asserted-by":"publisher","first-page":"19482","DOI":"10.1038\/s41598-021-98965-y","volume":"11","author":"MS Schubert","year":"2021","unstructured":"Schubert, M. S., Thommandru, B., Woodley, J., Turk, R., Yan, S., Kurgan, G., et al. (2021). Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair. Scientific Reports., 11(1), 19482.","journal-title":"Scientific Reports."},{"issue":"5","key":"1563_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","volume":"15","author":"PK Mandal","year":"2014","unstructured":"Mandal, P. K., Ferreira, L. M., Collins, R., Meissner, T. B., Boutwell, C. L., Friesen, M., et al. (2014). Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9. Cell Stem Cell, 15(5), 643\u2013652.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1563_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15053-x","volume":"11","author":"NS McCarty","year":"2020","unstructured":"McCarty, N. S., Graham, A. E., Studen\u00e1, L., & Ledesma-Amaro, R. (2020). Multiplexed CRISPR technologies for gene editing and transcriptional regulation. Nature Communications, 11(1), Article 1281.","journal-title":"Nature Communications"},{"issue":"1","key":"1563_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83259-0","volume":"11","author":"T Nakanishi","year":"2021","unstructured":"Nakanishi, T., Maekawa, A., Suzuki, M., Tabata, H., Sato, K., Mori, M., et al. (2021). Construction of adenovirus vectors simultaneously expressing four multiplex, double-nicking guide RNAs of CRISPR\/Cas9 and in vivo genome editing. Scientific Reports, 11(1), Article 3961.","journal-title":"Scientific Reports"},{"issue":"7681","key":"1563_CR40","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., et al. (2017). Programmable base editing of A T to G C in genomic DNA without DNA cleavage. Nature, 551(7681), 464\u2013471.","journal-title":"Nature"},{"issue":"7603","key":"1563_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 533(7603), 420\u2013424.","journal-title":"Nature"},{"issue":"11","key":"1563_CR42","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/nprot.2013.132","volume":"8","author":"MH Larson","year":"2013","unstructured":"Larson, M. H., Gilbert, L. A., Wang, X., Lim, W. A., Weissman, J. S., & Qi, L. S. (2013). CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nature Protocols, 8(11), 2180\u20132196.","journal-title":"Nature Protocols"},{"issue":"1","key":"1563_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1318-8","volume":"18","author":"PI Kulcs\u00e1r","year":"2017","unstructured":"Kulcs\u00e1r, P. I., T\u00e1las, A., Husz\u00e1r, K., Ligeti, Z., T\u00f3th, E., Weinhardt, N., et al. (2017). Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage. Genome Biology, 18(1), Article 190.","journal-title":"Genome Biology"},{"issue":"6268","key":"1563_CR44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aad5227","volume":"351","author":"IM Slaymaker","year":"2016","unstructured":"Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016). Rationally engineered Cas9 nucleases with improved specificity. Science, 351(6268), 84\u201388.","journal-title":"Science"},{"issue":"6","key":"1563_CR45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D., Gane, E., Taubel, J., Kao, J., Fontana, M., Maitland, M. L., et al. (2021). CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. New England Journal of Medicine, 385(6), 493\u2013502.","journal-title":"New England Journal of Medicine"},{"issue":"7699","key":"1563_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","volume":"556","author":"JH Hu","year":"2018","unstructured":"Hu, J. H., Miller, S. M., Geurts, M. H., Tang, W., Chen, L., Sun, N., et al. (2018). Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature, 556(7699), 57\u201363.","journal-title":"Nature"},{"issue":"6408","key":"1563_CR47","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1126\/science.aas9129","volume":"361","author":"H Nishimasu","year":"2018","unstructured":"Nishimasu, H., Shi, X., Ishiguro, S., Gao, L., Hirano, S., Okazaki, S., et al. (2018). Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science, 361(6408), 1259\u20131262.","journal-title":"Science"},{"issue":"1","key":"1563_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0817-8","volume":"16","author":"AE Friedland","year":"2015","unstructured":"Friedland, A. E., Baral, R., Singhal, P., Loveluck, K., Shen, S., Sanchez, M., et al. (2015). Characterization of Staphylococcus aureus Cas9: A smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications. Genome Biology, 16(1), Article 257.","journal-title":"Genome Biology"},{"issue":"4","key":"1563_CR49","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.molcel.2018.12.003","volume":"73","author":"A Edraki","year":"2019","unstructured":"Edraki, A., Mir, A., Ibraheim, R., Gainetdinov, I., Yoon, Y., Song, C.-Q., et al. (2019). A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing. Molecular cell., 73(4), 714\u2013726.","journal-title":"Molecular cell."},{"key":"1563_CR50","unstructured":"CRISPR-Cas R. CRISPR-CasF from huge phages is a hypercompact genome editor."},{"issue":"20","key":"1563_CR51","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1016\/j.molcel.2021.08.008","volume":"81","author":"X Xu","year":"2021","unstructured":"Xu, X., Chemparathy, A., Zeng, L., Kempton, H. R., Shang, S., Nakamura, M., et al. (2021). Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing. Molecular cell., 81(20), 4333\u20134345.","journal-title":"Molecular cell."},{"issue":"9","key":"1563_CR52","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.celrep.2016.02.018","volume":"14","author":"J-B Renaud","year":"2016","unstructured":"Renaud, J.-B., Boix, C., Charpentier, M., De Cian, A., Cochennec, J., Duvernois-Berthet, E., et al. (2016). Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases. Cell reports., 14(9), 2263\u20132272.","journal-title":"Cell reports."},{"issue":"7","key":"1563_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.167974","volume":"435","author":"BJ Pons","year":"2023","unstructured":"Pons, B. J., van Houte, S., Westra, E. R., & Chevallereau, A. (2023). Ecology and evolution of phages encoding anti-CRISPR proteins. Journal of Molecular Biology, 435(7), Article 167974.","journal-title":"Journal of Molecular Biology"},{"issue":"5","key":"1563_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41592-020-0771-6","volume":"17","author":"ND Marino","year":"2020","unstructured":"Marino, N. D., Pinilla-Redondo, R., Cs\u00f6rg\u0151, B., & Bondy-Denomy, J. (2020). Anti-CRISPR protein applications: Natural brakes for CRISPR-Cas technologies. Nature Methods, 17(5), 471\u2013479.","journal-title":"Nature Methods"},{"key":"1563_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-97-1777-4","volume-title":"Translational research in biomedical sciences: Recent progress and future prospects","author":"K Parthasarathy","year":"2024","unstructured":"Parthasarathy, K., & Manikkam, R. (2024). Translational research in biomedical sciences: Recent progress and future prospects. Springer."},{"issue":"7987","key":"1563_CR56","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41586-023-06612-5","volume":"623","author":"S Camara-Wilpert","year":"2023","unstructured":"Camara-Wilpert, S., Mayo-Mu\u00f1oz, D., Russel, J., Fagerlund, R. D., Madsen, J. S., Fineran, P. C., et al. (2023). Bacteriophages suppress CRISPR\u2013Cas immunity using RNA-based anti-CRISPRs. Nature, 623(7987), 601\u2013607.","journal-title":"Nature"},{"issue":"22","key":"1563_CR57","doi-asserted-by":"publisher","first-page":"13490","DOI":"10.1093\/nar\/gkae1006","volume":"52","author":"L Chou-Zheng","year":"2024","unstructured":"Chou-Zheng, L., Howell, O., Boyle, T. A., Hossain, M., Walker, F. C., Sheriff, E. K., et al. (2024). AcrIIIA1 is a protein\u2013RNA anti-CRISPR complex that targets core Cas and accessory nucleases. Nucleic Acids Research, 52(22), 13490\u201313514.","journal-title":"Nucleic Acids Research"},{"issue":"11","key":"1563_CR58","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41592-018-0178-9","volume":"15","author":"F Bubeck","year":"2018","unstructured":"Bubeck, F., Hoffmann, M. D., Harteveld, Z., Aschenbrenner, S., Bietz, A., Waldhauer, M. C., et al. (2018). Engineered anti-CRISPR proteins for optogenetic control of CRISPR\u2013Cas9. Nature methods., 15(11), 924\u2013927.","journal-title":"Nature methods."},{"issue":"13","key":"1563_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/nar\/gkz271","volume":"47","author":"MD Hoffmann","year":"2019","unstructured":"Hoffmann, M. D., Aschenbrenner, S., Grosse, S., Rapti, K., Domenger, C., Fakhiri, J., et al. (2019). Cell-specific CRISPR\u2013Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins. Nucleic acids research., 47(13), 75.","journal-title":"Nucleic acids research."},{"issue":"11","key":"1563_CR60","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1261\/rna.071704.119","volume":"25","author":"J Lee","year":"2019","unstructured":"Lee, J., Mou, H., Ibraheim, R., Liang, S.-Q., Liu, P., Xue, W., et al. (2019). Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins. RNA, 25(11), 1421\u20131431.","journal-title":"RNA"},{"key":"1563_CR61","doi-asserted-by":"publisher","first-page":"1138596","DOI":"10.3389\/fbioe.2023.1138596","volume":"11","author":"R Ewaisha","year":"2023","unstructured":"Ewaisha, R., & Anderson, K. S. (2023). Immunogenicity of CRISPR therapeutics\u2014Critical considerations for clinical translation. Frontiers in Bioengineering and Biotechnology., 11, 1138596.","journal-title":"Frontiers in Bioengineering and Biotechnology."},{"issue":"2","key":"1563_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tips.2021.10.012","volume":"43","author":"AE Modell","year":"2022","unstructured":"Modell, A. E., Lim, D., Nguyen, T. M., Sreekanth, V., & Choudhary, A. (2022). CRISPR-based therapeutics: Current challenges and future applications. Trends in pharmacological sciences., 43(2), 151\u2013161.","journal-title":"Trends in pharmacological sciences."},{"issue":"7631","key":"1563_CR63","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","volume":"540","author":"K Suzuki","year":"2016","unstructured":"Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., Wu, J., Zhu, J., Kim, E. J., et al. (2016). In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration. Nature, 540(7631), 144\u2013149.","journal-title":"Nature"},{"issue":"7629","key":"1563_CR64","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature20134","volume":"539","author":"DP Dever","year":"2016","unstructured":"Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., et al. (2016). CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells. Nature, 539(7629), 384\u2013389.","journal-title":"Nature"},{"issue":"4","key":"1563_CR65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.stem.2020.01.019","volume":"26","author":"MH Geurts","year":"2020","unstructured":"Geurts, M. H., de Poel, E., Amatngalim, G. D., Oka, R., Meijers, F. M., Kruisselbrink, E., et al. (2020). CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid biobank. Cell Stem Cell, 26(4), 503\u2013510.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"1563_CR66","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","volume":"38","author":"NM Gaudelli","year":"2020","unstructured":"Gaudelli, N. M., Lam, D. K., Rees, H. A., Sol\u00e1-Esteves, N. M., Barrera, L. A., Born, D. A., et al. (2020). Directed evolution of adenine base editors with increased activity and therapeutic application. Nature biotechnology., 38(7), 892\u2013900.","journal-title":"Nature biotechnology."},{"key":"1563_CR67","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/978-1-4939-6964-7_14","volume-title":"Reverse genetics of RNA viruses: Methods and protocols","author":"A Nogales","year":"2017","unstructured":"Nogales, A., Perez, D. R., Santos, J., Finch, C., & Mart\u00ednez-Sobrido, L. (2017). Reverse genetics of influenza B viruses. Reverse genetics of RNA viruses: Methods and protocols (pp. 205\u2013238). Springer."},{"issue":"12","key":"1563_CR68","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees, H. A., & Liu, D. R. (2018). Base editing: Precision chemistry on the genome and transcriptome of living cells. Nature reviews genetics., 19(12), 770\u2013788.","journal-title":"Nature reviews genetics."},{"issue":"7785","key":"1563_CR69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., et al. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature, 576(7785), 149\u2013157.","journal-title":"Nature"},{"issue":"3","key":"1563_CR70","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41576-022-00541-1","volume":"24","author":"PJ Chen","year":"2023","unstructured":"Chen, P. J., & Liu, D. R. (2023). Prime editing for precise and highly versatile genome manipulation. Nature Reviews Genetics, 24(3), 161\u2013177.","journal-title":"Nature Reviews Genetics"},{"issue":"7","key":"1563_CR71","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020). Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors. Nature Biotechnology, 38(7), 824\u2013844.","journal-title":"Nature Biotechnology"},{"issue":"12","key":"1563_CR72","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/procel\/pwad013","volume":"14","author":"J Liu","year":"2023","unstructured":"Liu, J., Chen, Y., Nong, B., Luo, X., Cui, K., Li, Z., et al. (2023). CRISPR-assisted transcription activation by phase-separation proteins. Protein & Cell, 14(12), 874\u2013887.","journal-title":"Protein & Cell"},{"issue":"6","key":"1563_CR73","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41587-021-01201-1","volume":"40","author":"S Erwood","year":"2022","unstructured":"Erwood, S., Bily, T. M., Lequyer, J., Yan, J., Gulati, N., Brewer, R. A., et al. (2022). Saturation variant interpretation using CRISPR prime editing. Nature Biotechnology, 40(6), 885\u2013895.","journal-title":"Nature Biotechnology"},{"issue":"24","key":"1563_CR74","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1093\/hmg\/ddac157","volume":"31","author":"L Zhang","year":"2022","unstructured":"Zhang, L., Sarangi, V., Liu, D., Ho, M.-F., Grassi, A. R., Wei, L., et al. (2022). ACE2 and TMPRSS2 SARS-CoV-2 infectivity genes: Deep mutational scanning and characterization of missense variants. Human Molecular Genetics, 31(24), 4183\u20134192.","journal-title":"Human Molecular Genetics"},{"key":"1563_CR75","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/bs.pmbts.2021.01.007","volume":"180","author":"S Ghavami","year":"2021","unstructured":"Ghavami, S., & Pandi, A. (2021). CRISPR interference and its applications. Progress in Molecular Biology and Translational Science, 180, 123\u2013140.","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"7","key":"1563_CR76","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.ymthe.2023.03.024","volume":"31","author":"L Bendixen","year":"2023","unstructured":"Bendixen, L., Jensen, T. I., & Bak, R. O. (2023). CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi. Molecular Therapy, 31(7), 1920\u20131937.","journal-title":"Molecular Therapy"},{"issue":"4","key":"1563_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/biot.202000308","volume":"16","author":"PG Schweickert","year":"2021","unstructured":"Schweickert, P. G., Wang, N., Sandefur, S. L., Lloyd, M. E., Konieczny, S. F., Frye, C. C., et al. (2021). CRISPR\/Cas12a\u2010mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction. Biotechnology Journal, 16(4), Article 2000308.","journal-title":"Biotechnology Journal"},{"issue":"3","key":"1563_CR78","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/s41596-021-00666-3","volume":"17","author":"LM Riedmayr","year":"2022","unstructured":"Riedmayr, L. M., Hinrichsmeyer, K. S., Karguth, N., B\u00f6hm, S., Splith, V., Michalakis, S., et al. (2022). dCas9-VPR-mediated transcriptional activation of functionally equivalent genes for gene therapy. Nature Protocols., 17(3), 781\u2013818.","journal-title":"Nature Protocols."},{"key":"1563_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.590989","volume":"11","author":"H Lin","year":"2021","unstructured":"Lin, H., Li, G., Peng, X., Deng, A., Ye, L., Shi, L., et al. (2021). The use of CRISPR\/Cas9 as a tool to study human infectious viruses. Frontiers in Cellular and Infection Microbiology, 11, Article 590989.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"1","key":"1563_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.130","volume":"59","author":"AB Banta","year":"2020","unstructured":"Banta, A. B., Ward, R. D., Tran, J. S., Bacon, E. E., & Peters, J. M. (2020). Programmable gene knockdown in diverse bacteria using Mobile\u2010CRISPRi. Current Protocols in Microbiology, 59(1), Article e130.","journal-title":"Current Protocols in Microbiology"},{"issue":"1","key":"1563_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/srep23146","volume":"6","author":"PC Roehm","year":"2016","unstructured":"Roehm, P. C., Shekarabi, M., Wollebo, H. S., Bellizzi, A., He, L., Salkind, J., et al. (2016). Inhibition of HSV-1 replication by gene editing strategy. Scientific Reports, 6(1), Article 23146.","journal-title":"Scientific Reports"},{"issue":"19","key":"1563_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914865","volume":"24","author":"R Cai","year":"2023","unstructured":"Cai, R., Lv, R., Shi, X., Yang, G., & Jin, J. (2023). CRISPR\/dCas9 tools: Epigenetic mechanism and application in gene transcriptional regulation. International Journal of Molecular Sciences, 24(19), Article 14865.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1563_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01695-x","volume":"8","author":"J Lian","year":"2017","unstructured":"Lian, J., HamediRad, M., Hu, S., & Zhao, H. (2017). Combinatorial metabolic engineering using an orthogonal tri-functional CRISPR system. Nature Communications, 8(1), Article 1688.","journal-title":"Nature Communications"},{"issue":"7","key":"1563_CR84","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.cell.2018.10.024","volume":"175","author":"E Shifrut","year":"2018","unstructured":"Shifrut, E., Carnevale, J., Tobin, V., Roth, T. L., Woo, J. M., Bui, C. T., et al. (2018). Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function. Cell, 175(7), 1958\u201371. e15.","journal-title":"Cell"},{"issue":"33","key":"1563_CR85","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1073\/pnas.1512503112","volume":"112","author":"K Schumann","year":"2015","unstructured":"Schumann, K., Lin, S., Boyer, E., Simeonov, D. R., Subramaniam, M., Gate, R. E., et al. (2015). Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proceedings of the National Academy of Sciences., 112(33), 10437\u201310442.","journal-title":"Proceedings of the National Academy of Sciences."},{"issue":"1","key":"1563_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-00462-8","volume":"7","author":"LJ Rupp","year":"2017","unstructured":"Rupp, L. J., Schumann, K., Roybal, K. T., Gate, R. E., Ye, C. J., Lim, W. A., et al. (2017). CRISPR\/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells. Scientific Reports, 7(1), 1\u201310.","journal-title":"Scientific Reports"},{"issue":"25","key":"1563_CR87","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1016\/j.cell.2021.11.016","volume":"184","author":"CR Good","year":"2021","unstructured":"Good, C. R., Aznar, M. A., Kuramitsu, S., Samareh, P., Agarwal, S., Donahue, G., et al. (2021). An NK-like CAR T cell transition in CAR T cell dysfunction. Cell, 184(25), 6081\u2013100. e26.","journal-title":"Cell"},{"issue":"5","key":"1563_CR88","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0092-8674(00)00078-7","volume":"102","author":"M Muramatsu","year":"2000","unstructured":"Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000). Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell, 102(5), 553\u2013563.","journal-title":"Cell"},{"issue":"1","key":"1563_CR89","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ymthe.2025.09.001","volume":"34","author":"H Liu","year":"2026","unstructured":"Liu, H., Singh, S., Mullen, T. J., Bullock, C., Keegan, S., Patterson, T., et al. (2026). A precision gene-engineered B cell medicine producing sustained levels of active factor IX for Hemophilia B therapy. Molecular Therapy, 34(1), 266\u2013280.","journal-title":"Molecular Therapy"},{"key":"1563_CR90","doi-asserted-by":"crossref","unstructured":"Lee, J., Boczkowski, D., & Nair, S. (2012) Programming human dendritic cells with mRNA. Synthetic messenger RNA and Cell metabolism modulation: Methods and protocols. Springer 111-25","DOI":"10.1007\/978-1-62703-260-5_8"},{"issue":"6","key":"1563_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270008","volume":"17","author":"K Omachi","year":"2022","unstructured":"Omachi, K., & Miner, J. H. (2022). Comparative analysis of dCas9-VP64 variants and multiplexed guide RNAs mediating CRISPR activation. PLoS ONE, 17(6), Article e0270008.","journal-title":"PLoS ONE"},{"issue":"11","key":"1563_CR92","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41592-020-0966-x","volume":"17","author":"N Alerasool","year":"2020","unstructured":"Alerasool, N., Segal, D., Lee, H., & Taipale, M. (2020). An efficient KRAB domain for CRISPRi applications in human cells. Nature Methods, 17(11), 1093\u20131096.","journal-title":"Nature Methods"},{"issue":"3","key":"1563_CR93","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","volume":"384","author":"H Frangoul","year":"2021","unstructured":"Frangoul, H., Altshuler, D., Cappellini, M. D., Chen, Y.-S., Domm, J., Eustace, B. K., et al. (2021). CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. New England Journal of Medicine, 384(3), 252\u2013260.","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"1563_CR94","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41590-019-0500-4","volume":"20","author":"G Wang","year":"2019","unstructured":"Wang, G., Chow, R. D., Bai, Z., Zhu, L., Errami, Y., Dai, X., et al. (2019). Multiplexed activation of endogenous genes by CRISPRa elicits potent antitumor immunity. Nature Immunology, 20(11), 1494\u20131505.","journal-title":"Nature Immunology"},{"issue":"6537","key":"1563_CR95","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba1786","volume":"372","author":"EW Weber","year":"2021","unstructured":"Weber, E. W., Parker, K. R., Sotillo, E., Lynn, R. C., Anbunathan, H., Lattin, J., et al. (2021). Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science, 372(6537), Article eaba1786.","journal-title":"Science"},{"key":"1563_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116738","author":"A Huber","year":"2026","unstructured":"Huber, A., Djajawi, T. M., Rivera, I. S., Vervoort, S. J., & Kearney, C. J. (2026). CRISPR screens define unified hallmarks of cancer cell-autonomous immune evasion. Cell Reports. https:\/\/doi.org\/10.1016\/j.celrep.2025.116738","journal-title":"Cell Reports"},{"issue":"1","key":"1563_CR97","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/imr.13244","volume":"320","author":"D Hoces","year":"2023","unstructured":"Hoces, D., Miguens Blanco, J., & Hern\u00e1ndez\u2010L\u00f3pez, R. A. (2023). A synthetic biology approach to engineering circuits in immune cells. Immunological Reviews, 320(1), 120\u2013137.","journal-title":"Immunological Reviews"},{"issue":"6","key":"1563_CR98","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nmeth.4278","volume":"14","author":"SQ Tsai","year":"2017","unstructured":"Tsai, S. Q., Nguyen, N. T., Malagon-Lopez, J., Topkar, V. V., Aryee, M. J., & Joung, J. K. (2017). CIRCLE-seq: A highly sensitive in vitro screen for genome-wide CRISPR\u2013Cas9 nuclease off-targets. Nature Methods, 14(6), 607\u2013614.","journal-title":"Nature Methods"},{"issue":"2","key":"1563_CR99","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., et al. (2015). GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nature biotechnology., 33(2), 187\u2013197.","journal-title":"Nature biotechnology."},{"issue":"3","key":"1563_CR100","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nmeth.3284","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Bae, S., Park, J., Kim, E., Kim, S., Yu, H. R., et al. (2015). Digenome-seq: Genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nature Methods, 12(3), 237\u2013243.","journal-title":"Nature Methods"},{"issue":"8","key":"1563_CR101","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K., & Bradley, A. (2018). Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements. Nature Biotechnology, 36(8), 765\u2013771.","journal-title":"Nature Biotechnology"},{"issue":"1","key":"1563_CR102","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41392-023-01309-7","volume":"8","author":"T Li","year":"2023","unstructured":"Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., et al. (2023). CRISPR\/Cas9 therapeutics: Progress and prospects. Signal Transduction and Targeted Therapy, 8(1), 36.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"12","key":"1563_CR103","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1016\/S2214-109X(18)30346-2","volume":"6","author":"D Gouglas","year":"2018","unstructured":"Gouglas, D., Le, T. T., Henderson, K., Kaloudis, A., Danielsen, T., Hammersland, N. C., et al. (2018). Estimating the cost of vaccine development against epidemic infectious diseases: A cost minimisation study. The Lancet Global Health, 6(12), e1386\u2013e1396.","journal-title":"The Lancet Global Health"},{"key":"1563_CR104","unstructured":"Investigational HGT. (2020) Chemistry, manufacturing, and control (CMC) information for human gene therapy investigational new drug applications (INDs) guidance for industry. Center for Biologics Evaluation and Research"},{"issue":"1","key":"1563_CR105","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jmb.2018.05.044","volume":"431","author":"C Brokowski","year":"2019","unstructured":"Brokowski, C., & Adli, M. (2019). CRISPR ethics: Moral considerations for applications of a powerful tool. Journal of Molecular Biology, 431(1), 88\u2013101.","journal-title":"Journal of Molecular Biology"},{"key":"1563_CR106","volume-title":"Medicine NAo, editing ICotCUoHGG","author":"Society TR","year":"2021","unstructured":"Society TR. (2021). Medicine NAo, editing ICotCUoHGG. National Academies Press."},{"key":"1563_CR107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1332939","volume":"15","author":"B Lu","year":"2024","unstructured":"Lu, B., Lim, J. M., Yu, B., Song, S., Neeli, P., Sobhani, N., et al. (2024). The next-generation DNA vaccine platforms and delivery systems: Advances, challenges and prospects. Frontiers in Immunology, 15, Article 1332939.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"1563_CR108","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W., & Gao, G. (2021). Viral vector platforms within the gene therapy landscape. Signal Transduction and Targeted Therapy, 6(1), 53.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1563_CR109","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.omtm.2023.01.006","volume":"28","author":"K Krotova","year":"2023","unstructured":"Krotova, K., Kuoch, H., Caine, C., & Aslanidi, G. (2023). Tumor antigen-loaded AAV vaccine drives protective immunity in a melanoma animal model. Molecular Therapy Methods & Clinical Development, 28, 301\u2013311.","journal-title":"Molecular Therapy Methods & Clinical Development"},{"issue":"11","key":"1563_CR110","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3390\/pharmaceutics16111360","volume":"16","author":"N Mnyandu","year":"2024","unstructured":"Mnyandu, N., Jacobs, R., Arbuthnot, P., & Maepa, M. B. (2024). Recent advances in designing Adeno-associated virus-based vaccines against viral infections. Pharmaceutics, 16(11), 1360.","journal-title":"Pharmaceutics"},{"key":"1563_CR111","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.omtm.2018.11.009","volume":"12","author":"A Li","year":"2019","unstructured":"Li, A., Lee, C. M., Hurley, A. E., Jarrett, K. E., De Giorgi, M., Lu, W., et al. (2019). A self-deleting AAV-CRISPR system for in vivo genome editing. Molecular Therapy Methods & Clinical Development, 12, 111\u2013122.","journal-title":"Molecular Therapy Methods & Clinical Development"},{"issue":"1","key":"1563_CR112","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41467-021-21213-4","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y., Feng, F., Hu, G., Wang, Y., Yu, Y., Zhu, Y., et al. (2021). A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry. Nature Communications, 12(1), 961.","journal-title":"Nature Communications"},{"issue":"2","key":"1563_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/v10020081","volume":"10","author":"P Chang","year":"2018","unstructured":"Chang, P., Yao, Y., Tang, N., Sadeyen, J.-R., Sealy, J., Clements, A., et al. (2018). The application of NHEJ-CRISPR\/Cas9 and Cre-Lox system in the generation of bivalent duck enteritis virus vaccine against Avian influenza virus. Viruses, 10(2), Article 81.","journal-title":"Viruses"},{"key":"1563_CR114","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01036-18","author":"DJ Davido","year":"2018","unstructured":"Davido, D. J., Tu, E. M., Wang, H., Korom, M., Gazquez Casals, A., Reddy, P. J., et al. (2018). Attenuated herpes simplex virus 1 (HSV-1) expressing a mutant form of ICP6 stimulates a strong immune response that protects mice against HSV-1-induced corneal disease. Journal of Virology. https:\/\/doi.org\/10.1128\/jvi.01036-18","journal-title":"Journal of Virology"},{"key":"1563_CR115","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02342-16","author":"DJ Royer","year":"2017","unstructured":"Royer, D. J., Carr, M. M., Chucair-Elliott, A. J., Halford, W. P., & Carr, D. J. (2017). Impact of type I interferon on the safety and immunogenicity of an experimental live-attenuated herpes simplex virus 1 vaccine in mice. Journal of Virology. https:\/\/doi.org\/10.1128\/jvi.02342-16","journal-title":"Journal of Virology"},{"issue":"6","key":"1563_CR116","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1134\/S0006297925601212","volume":"90","author":"AA Kazakova","year":"2025","unstructured":"Kazakova, A. A., Leonova, E. I., Sopova, J. V., Chirinskaite, A. V., Minskaya, E. S., Kukushkin, I. S., et al. (2025). Progress in CRISPR\/Cas13-mediated suppression of Influenza A and SARS-CoV-2 virus infection in in vitro and in vivo models. Biochemistry (Moscow), 90(6), 786\u2013803.","journal-title":"Biochemistry (Moscow)"},{"issue":"1","key":"1563_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65768-y","volume":"16","author":"H-P Wen","year":"2025","unstructured":"Wen, H.-P., Yu, C., Bi, S., Jiang, L.-H., Wang, Z.-G., Yao, Z., et al. (2025). Programmable targeted RNA degradation via dCas13d-directed chaperone-mediated autophagy (dCasCMA). Nature Communications, 16(1), Article 10738.","journal-title":"Nature Communications"},{"key":"1563_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100245","author":"X Lin","year":"2021","unstructured":"Lin, X., Liu, Y., Chemparathy, A., Pande, T., La Russa, M., & Qi, L. S. (2021). A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses. Cell Reports Medicine. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100245","journal-title":"Cell Reports Medicine"},{"key":"1563_CR119","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/9781394271566.ch6","volume-title":"Viral vectors for vaccine delivery","author":"D Arora","year":"2025","unstructured":"Arora, D., Taneja, Y., Gulati, D., Kumar, M., Pareek, A., & Gautam, R. K. (2025). Genetically modified viral vectors for vaccine delivery. Viral vectors for vaccine delivery (pp. 149\u2013177)"},{"issue":"20","key":"1563_CR120","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.cell.2024.07.052","volume":"187","author":"AA Cohen","year":"2024","unstructured":"Cohen, A. A., Keeffe, J. R., Schiepers, A., Dross, S. E., Greaney, A. J., Rorick, A. V., et al. (2024). Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals. Cell, 187(20), 5554\u20135571.","journal-title":"Cell"},{"issue":"6","key":"1563_CR121","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/s41591-025-03728-1","volume":"31","author":"N Ndembi","year":"2025","unstructured":"Ndembi, N., Mutesa, L., Muvunyi, C. M., & Kim, J. H. (2025). Bridging the vaccine divide. Nature Medicine., 31(6), 1737.","journal-title":"Nature Medicine."},{"issue":"S6","key":"1563_CR122","doi-asserted-by":"publisher","first-page":"S414","DOI":"10.2105\/AJPH.2014.302236r","volume":"108","author":"SE Crager","year":"2018","unstructured":"Crager, S. E. (2018). Improving global access to new vaccines: Intellectual property, technology transfer, and regulatory pathways. American Journal of Public Health, 108(S6), S414\u2013S420.","journal-title":"American Journal of Public Health"},{"issue":"18","key":"1563_CR123","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.vaccine.2023.03.055","volume":"41","author":"MF Criado","year":"2023","unstructured":"Criado, M. F., Kassa, A., Bertran, K., Kwon, J.-H., e Silva MS, Killmaster L, et al. (2023). Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses. Vaccine., 41(18), 2893\u20132904.","journal-title":"Vaccine."},{"issue":"1","key":"1563_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13072-024-00564-4","volume":"18","author":"P Letchumanan","year":"2025","unstructured":"Letchumanan, P., & Theva Das, K. (2025). The role of genetic diversity, epigenetic regulation, and sex-based differences in HIV cure research: A comprehensive review. Epigenetics & Chromatin, 18(1), 1.","journal-title":"Epigenetics & Chromatin"},{"key":"1563_CR125","unstructured":"Ernst D. (2023) CRISPR-based gene therapy candidate fast tracked for HIV treatment. Infectious Disease Advisor. NA-NA."},{"key":"1563_CR126","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41587-023-02022-0","volume":"41","author":"C Sheridan","year":"2023","unstructured":"Sheridan, C. (2023). Can gene editing drive out HIV and hepatitis viruses from inside cells? Nature Biotechnology, 41, 1491\u20131493.","journal-title":"Nature Biotechnology"},{"key":"1563_CR127","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/9781119719809.ch30","volume-title":"Rossi's principles of transfusion medicine","author":"RM Fasano","year":"2022","unstructured":"Fasano, R. M., Meier, E. R., & Chonat, S. (2022). Sickle cell disease, thalassemia, and hereditary hemolytic anemias. Rossi\u2019s principles of transfusion medicine (pp. 326\u2013345)"},{"issue":"11","key":"1563_CR128","doi-asserted-by":"publisher","first-page":"20190604","DOI":"10.1042\/BSR20190604","volume":"39","author":"J Yin","year":"2019","unstructured":"Yin, J., Xie, X., Ye, Y., Wang, L., & Che, F. (2019). BCL11A: A potential diagnostic biomarker and therapeutic target in human diseases. Bioscience Reports., 39(11), 20190604.","journal-title":"Bioscience Reports."},{"key":"1563_CR129","doi-asserted-by":"crossref","unstructured":"Tripathi MK, Kumar P, Jose B, Mondal S, Sarma K. (2023) CRISPR-CAS 9 and its application as therapeutics for \u03b2-Haemoglobinopathies. Exploratory Animal & Medical Research. 13(1)","DOI":"10.52635\/eamr\/13.1.8-15"},{"issue":"08","key":"1563_CR130","first-page":"20","volume":"20","author":"M Stevanovic","year":"2024","unstructured":"Stevanovic, M. (2024). Treatment and technology: The future of retina care. Ophthalmology Times, 20(08), 20\u201321.","journal-title":"Ophthalmology Times"},{"issue":"21","key":"1563_CR131","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","volume":"390","author":"EA Pierce","year":"2024","unstructured":"Pierce, E. A., Aleman, T. S., Jayasundera, K. T., Ashimatey, B. S., Kim, K., Rashid, A., et al. (2024). Gene editing for CEP290-associated retinal degeneration. New England Journal of Medicine, 390(21), 1972\u20131984.","journal-title":"New England Journal of Medicine"},{"key":"1563_CR132","first-page":"657557","volume":"06","author":"S Rathi","year":"2025","unstructured":"Rathi, S., Didangelos, A., Pisarenka, S., Green, R., Emery-Billcliff, P., Patel, N., et al. (2025). CTx001 for geographic atrophy: A gene therapy expressing soluble, truncated complement receptor 1 (mini-CR1). Biorxiv., 06, 657557.","journal-title":"Biorxiv."},{"issue":"8","key":"1563_CR133","first-page":"4336","volume":"66","author":"D Keefe","year":"2025","unstructured":"Keefe, D., Didangelos, A., Pisarenka, S., Chaudhuri, S., Emery-Billcliff, P., Patel, N., et al. (2025). CTx001, an AAV2 complement inhibitor gene therapy in nonclinical development for dry AMD, attenuates alternative and classical complement pathway activation in vitro and in vivo. Investigative Ophthalmology & Visual Science., 66(8), 4336.","journal-title":"Investigative Ophthalmology & Visual Science."},{"issue":"7","key":"1563_CR134","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.trecan.2018.05.006","volume":"4","author":"C-H Huang","year":"2018","unstructured":"Huang, C.-H., Lee, K.-C., & Doudna, J. A. (2018). Applications of CRISPR-Cas enzymes in cancer therapeutics and detection. Trends in Cancer, 4(7), 499\u2013512.","journal-title":"Trends in Cancer"},{"issue":"7630","key":"1563_CR135","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature.2016.20988","volume":"539","author":"D Cyranoski","year":"2016","unstructured":"Cyranoski, D. (2016). CRISPR gene-editing tested in a person for the first time. Nature, 539(7630), 479.","journal-title":"Nature"},{"key":"1563_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2025.02.006","author":"F Yang","year":"2025","unstructured":"Yang, F., Aliyari, S., Zhu, Z., Zheng, H., Cheng, G., & Zhang, S. (2025). CRISPR-Cas: A game-changer in vaccine development and the fight against viral infections. Trends in Microbiology. https:\/\/doi.org\/10.1016\/j.tim.2025.02.006","journal-title":"Trends in Microbiology"},{"issue":"4","key":"1563_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines7040207","volume":"7","author":"MO Atasoy","year":"2019","unstructured":"Atasoy, M. O., Rohaim, M. A., & Munir, M. (2019). Simultaneous deletion of virulence factors and insertion of antigens into the infectious laryngotracheitis virus using NHEJ-CRISPR\/Cas9 and cre\u2013lox system for construction of a stable vaccine vector. Vaccines, 7(4), Article 207.","journal-title":"Vaccines"},{"issue":"2","key":"1563_CR138","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s12033-023-00724-z","volume":"66","author":"F Morshedzadeh","year":"2024","unstructured":"Morshedzadeh, F., Ghanei, M., Lotfi, M., Ghasemi, M., Ahmadi, M., Najari-Hanjani, P., et al. (2024). An update on the application of CRISPR technology in clinical practice. Molecular biotechnology., 66(2), 179\u2013197.","journal-title":"Molecular biotechnology."},{"issue":"1","key":"1563_CR139","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/jcb.26165","volume":"119","author":"V Singh","year":"2018","unstructured":"Singh, V., Gohil, N., Ramirez Garcia, R., Braddick, D., & Fofi\u00e9, C. K. (2018). Recent advances in CRISPR\u2010Cas9 genome editing technology for biological and biomedical investigations. Journal of Cellular Biochemistry, 119(1), 81\u201394.","journal-title":"Journal of Cellular Biochemistry"},{"issue":"6","key":"1563_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/v16060973","volume":"16","author":"R Wallace","year":"2024","unstructured":"Wallace, R., Bliss, C. M., & Parker, A. L. (2024). The immune system\u2014A double-edged sword for adenovirus-based therapies. Viruses, 16(6), Article 973.","journal-title":"Viruses"},{"issue":"24","key":"1563_CR141","doi-asserted-by":"publisher","first-page":"E4812","DOI":"10.1073\/pnas.1704766114","volume":"114","author":"LV Tse","year":"2017","unstructured":"Tse, L. V., Klinc, K. A., Madigan, V. J., Castellanos Rivera, R. M., Wells, L. F., Havlik, L. P., et al. (2017). Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion. Proceedings of the National Academy of Sciences., 114(24), E4812\u2013E4821.","journal-title":"Proceedings of the National Academy of Sciences."},{"issue":"1","key":"1563_CR142","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","volume":"4","author":"F Mingozzi","year":"2017","unstructured":"Mingozzi, F., & High, K. A. (2017). Overcoming the host immune response to adeno-associated virus gene delivery vectors: The race between clearance, tolerance, neutralization, and escape. Annual Review of Virology, 4(1), 511\u2013534.","journal-title":"Annual Review of Virology"},{"issue":"3","key":"1563_CR143","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E., Wu, Y., Gemberling, M. P., Oliver, M. L., Waller, M. A., Bohning, J. D., et al. (2019). Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nature Medicine, 25(3), 427\u2013432.","journal-title":"Nature Medicine"},{"issue":"2","key":"1563_CR144","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T., Deshpande, P. S., Dever, D. P., Camarena, J., Lemgart, V. T., Cromer, M. K., et al. (2019). Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nature medicine., 25(2), 249\u2013254.","journal-title":"Nature medicine."},{"issue":"27","key":"1563_CR145","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., et al. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine, 383(27), 2603\u20132615.","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"1563_CR146","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021). Lipid nanoparticles for mRNA delivery. Nature Reviews Materials, 6(12), 1078\u20131094.","journal-title":"Nature Reviews Materials"},{"issue":"4","key":"1563_CR147","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nbt.3803","volume":"35","author":"YB Kim","year":"2017","unstructured":"Kim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017). Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nature Biotechnology, 35(4), 371\u2013376.","journal-title":"Nature Biotechnology"},{"issue":"7714","key":"1563_CR148","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","volume":"559","author":"TL Roth","year":"2018","unstructured":"Roth, T. L., Puig-Saus, C., Yu, R., Shifrut, E., Carnevale, J., Li, P. J., et al. (2018). Reprogramming human T cell function and specificity with non-viral genome targeting. Nature, 559(7714), 405\u2013409.","journal-title":"Nature"},{"issue":"1","key":"1563_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.130","volume":"59","author":"AB Banta","year":"2020","unstructured":"Banta, A. B., Ward, R. D., Tran, J. S., Bacon, E. E., & Peters, J. M. (2020). Programmable gene knockdown in diverse bacteria using Mobile-CRISPRi. Current Protocols in Microbiology, 59(1), Article e130.","journal-title":"Current Protocols in Microbiology"},{"issue":"4","key":"1563_CR150","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41423-020-00532-4","volume":"18","author":"S Federici","year":"2021","unstructured":"Federici, S., Nobs, S. P., & Elinav, E. (2021). Phages and their potential to modulate the microbiome and immunity. Cellular & Molecular Immunology, 18(4), 889\u2013904.","journal-title":"Cellular & Molecular Immunology"},{"issue":"5","key":"1563_CR151","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/med.21572","volume":"39","author":"K D\u0105browska","year":"2019","unstructured":"D\u0105browska, K. (2019). Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review. Medicinal Research Reviews, 39(5), 2000\u20132025.","journal-title":"Medicinal Research Reviews"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01563-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-026-01563-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-026-01563-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:02:42Z","timestamp":1781820162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-026-01563-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":151,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1563"],"URL":"https:\/\/doi.org\/10.1007\/s12033-026-01563-4","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethical committee of Ardabil University of Medical Sciences (Reference number: IR.ARUMS.REC.1404.380).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors declare agreement and consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that ChatGPT (GPT-5, OpenAI) was used to improve the English language and writing style of this manuscript. The authors reviewed and verified all AI-generated suggestions to ensure the accuracy and integrity of the final content.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of AI Assistance"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}